Dual derivatization strategy for the comprehensive quantification and double bond location characterization of fatty acids by ultra-high performance liquid chromatography-tandem mass spectrometry

J Chromatogr A. 2021 Feb 22:1639:461939. doi: 10.1016/j.chroma.2021.461939. Epub 2021 Jan 23.

Abstract

Comprehensive analysis of fatty acids (FAs) has long been challenging due to their poor ionization efficiency, lack of characteristic fragment ions and difficulty of identifying C=C bond locations. In this study, a high coverage ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was established for the quantification and C=C bond location characterization of FAs using two structural analogues, 2-hydrazinyl-4,6-dimethylpyrimidine (DMP) and 2-hydrazinylpyrimidine (DP), as dual derivatization reagents. DP-labeled FA standards were used as internal standards to reduced matrix effects, which guaranteed the accurate quantification of FAs. The derivatization yields of FAs were larger than 99% and the sensitivities were increased by 400-fold compared with non-derivatized FAs. Pretreatment and instrumental analysis of FAs can be completed in 20 minutes. Only 5 μL rat plasma can satisfy the quantification of 36 FAs with good linearity (r>0.99). Both intra-day and inter-day accuracies were in the range of 85-105%, and the precisions were less than 15%. The extraction recoveries were investigated to be in the range of 88-112%. No obvious matrix effects were observed for the derivatized FAs. In addition, the locations of C=C bonds in DMP-derivatized FAs could be identified by diagnostic fragment ions generated from 1,4-hydrogen elimination and allylic cleavage under low energy collision induced dissociation (CID). The new method was finally employed for FA profiling in plasma from rats with moxifloxacin-induced liver injury. Significant downregulation of butyric acid was observed in moxifloxacin treated model rats, which was believed to be related to the liver injury.

Keywords: Double bond location; Dual derivatization; Fatty acid; Moxifloxacin; UHPLC-MS/MS.

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Discriminant Analysis
  • Fatty Acids / analysis*
  • Fatty Acids / chemistry
  • Least-Squares Analysis
  • Liver / injuries
  • Liver / pathology
  • Male
  • Metabolic Networks and Pathways
  • Moxifloxacin / adverse effects
  • Rats
  • Rats, Wistar
  • Tandem Mass Spectrometry / methods*

Substances

  • Fatty Acids
  • Moxifloxacin